Eli Lilly (LLY)
(Delayed Data from NYSE)
$764.71 USD
+16.52 (2.21%)
Updated Sep 16, 2025 03:59 PM ET
After-Market: $764.00 -0.71 (-0.09%) 7:26 PM ET
3-Hold of 5 3
C Value C Growth D Momentum C VGM
Fundamental Charts
About Market Cap
As of the previous market close, Eli Lilly and Company has a market cap of $708.13B, which represents its share price of $748.19 multiplied by its outstanding shares number of 946.46M. As a large-cap company, LLY's shareholders are generally exposed to less risk than shareholders of small and mid-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
LLY 764.71 +16.52(2.21%)
Will LLY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for LLY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for LLY
Why the Market Dipped But Eli Lilly (LLY) Gained Today
AMGN vs. VKTX: Which Biotech Stock Is the Better Obesity Play?
LLY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is ABBV Stock a Buy, Hold, or Sell After Its Almost 23% Rise YTD?
Will Rybelsus' Updated EU Label Propel Fresh Growth Potential for NVO?
Lilly Moves Past 50-Day SMA: Should You Consider Buying the Stock Now?
Other News for LLY
Eli Lilly To Invest $5 Billion In New Virginia Manufacturing Facility To Support Cancer Drugs Manufacturing
Eli Lilly (LLY) Faces Investor Concerns Over Recent Trial Data
Eli Lilly's (LLY) Peresolimab Faces Efficacy Challenges in Rheumatoid Arthritis Treatment
Eli Lilly (LLY) Commits $5B to New Manufacturing Facility in Virginia
AnaptysBio falls after data abstract on Lilly’s peresolimab